Tempus

Tempus Unveils Early Results from Multimodal Foundation Model Research for Scalable Oncology Insights

Tempus Unveils Early Results from Multimodal Foundation Models, Demonstrating Potential to Accelerate Precision Oncology and Drug Development Tempus a technology company focused on advancing precision medicine through artificial intelligence, has announced new findings from its multimodal foundation model research at…

Read MoreTempus Unveils Early Results from Multimodal Foundation Model Research for Scalable Oncology Insights
Beren

Beren Therapeutics to Present Six Research Abstracts at the 2026 APMRF Conference

Beren Therapeutics to Present Six Posters Highlighting Clinical and Preclinical Progress of Adrabetadex at 2026 APMRF Conference Beren Therapeutics P.B.C., the parent company of Mandos LLC and a company focused on advancing cholesterol trafficking biology and cyclodextrin-based therapeutics, has announced…

Read MoreBeren Therapeutics to Present Six Research Abstracts at the 2026 APMRF Conference
Veracytes

Veracyte’s Prosigna Test Delivers Practice-Changing Results in Landmark OPTIMA Breast Cancer Study

Landmark OPTIMA Trial Demonstrates Veracyte’s Prosigna Test Can Safely Reduce Chemotherapy Use in High-Risk Breast Cancer Patients Veracyte has announced groundbreaking results from the OPTIMA (Optimal Personalised Treatment of Early Breast Cancer Using Multi-parameter Analysis) trial, a large independent Phase…

Read MoreVeracyte’s Prosigna Test Delivers Practice-Changing Results in Landmark OPTIMA Breast Cancer Study
Microbot

Microbot Medical Secures First International Regulatory Approval for LIBERTY Endovascular Robotic System

Microbot Medical Expands Global Reach as Israel Grants Marketing Approval for LIBERTY Endovascular Robotic System Microbot Medica a commercial-stage medical device company focused on advancing robotic technologies for endovascular procedures, has achieved a major regulatory milestone with the approval of…

Read MoreMicrobot Medical Secures First International Regulatory Approval for LIBERTY Endovascular Robotic System
NRC

NRC Health Introduces Ambient Listening and Agentic AI to Enhance Leader Rounding

NRC Health Introduces Ambient Listening and Agentic AI to Transform Leader Rounding and Healthcare Experience Management NRC Health has unveiled a significant advancement in healthcare experience management with the introduction of new artificial intelligence capabilities that combine ambient listening and…

Read MoreNRC Health Introduces Ambient Listening and Agentic AI to Enhance Leader Rounding
Life

Life Healthcare Strengthens Operations and Expands Capacity to Drive Strategic Execution

Life Healthcare Advances Strategic Growth Agenda with Capacity Expansion and Improved Operational Performance Life Healthcare Group has reported encouraging progress in the execution of its long-term growth strategy, delivering improved operational momentum and continued investment in healthcare infrastructure during the…

Read MoreLife Healthcare Strengthens Operations and Expands Capacity to Drive Strategic Execution
ASCO

ASCO 2026 Features Premier Research’s International Study on Multiple Myeloma Treatment

ASCO 2026 Highlights International Multiple Myeloma Research Collaboration Between Premier Applied Sciences and Mango Sciences The American Society of Clinical Oncology (ASCO) has spotlighted new research from Premier Applied Sciences (PAS) and Mango Sciences Inc. during the ASCO 2026 Annual…

Read MoreASCO 2026 Features Premier Research’s International Study on Multiple Myeloma Treatment
Encompass

Encompass Health to Enhance Rehabilitation Services with New Bridgeport Facility

Encompass Health Expands Rehabilitation Services with New 36-Bed Hospital in Bridgeport, West Virginia Encompass Health, a leading provider of inpatient rehabilitation services in the United States, has announced plans to develop a new freestanding inpatient rehabilitation hospital in Bridgeport, West…

Read MoreEncompass Health to Enhance Rehabilitation Services with New Bridgeport Facility